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Role of p63 in Keratinocyte Differentiation and Proliferation
A Costanzo1, B Marinari1, M Koster2, ML Giustizieri1, C Ballaro`3, S
Alema`3, M Karin4, DR Roop2 and S Chimenti1 1Department
of Dermatology University of Rome ‘‘Tor Vergata’’, Rome, Italy,
2Department of Molecular and Cellular Biology, Baylor College, Houston
TX, USA, 3Istituto di Biologia Cellulare, CNR, Italy and 4Department of
Pharmacology, UCSD, La Jolla, CA, USA
The p63 gene belongs to the p53 gene family of tumor suppressor genes
and encodes for sequence specific transcription factors. The DNp63
protein, lacking the canonical transactivation domain, has been
proposed to identify the epidermal stem cells and to regulate their
survival and self renewal. In an attempt to identify new potential p63
targets, we have found that the epidermal morphogenesis modulator
IKKalpha is tightly regulated at the transcriptional level by different
isoforms of p63. We have observed that IKKa mRNA expression increases
at the onset of the stratification program. The selective downregulation of
DNp63 by siRNA in primary keratinocytes abolishes IKKa activation and
the onset of terminal differentiation and increases keratinocyte prolifera-
tion rate. This is consistent with transcriptional assay data performed with
an IKKa-promoter reporter gene showing a strong activation of IKKa
transcription by DNp63 isoforms and a repressory activity of TAp63
isoforms. On the other hand, the downregulation of IKKa in primary
keratinocytes hampers the ability of differentiating cells to exit the cell
cycle inducing the formation of a K1 expressing proliferative layer that is
reminiscent of the embryonic intermediate layer and of squamous cell
carcinoma. Our results indicate IKKa as an important p63 target
potentially involved in the control of epidermal stem cells proliferation
in skin development and in cell transformation.
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Molecular Pathogenesis of Basal Cell Carcinoma
J Reifenberger
Department of Dermatology, Heinrich-Heine-University, Du¨sseldorf,
Germany
The hedgehog signalling pathway plays an important role in the
embryonic development of various organ systems including the skin.
Aberrant activation of hedgehog signalling by mutations in genes
encoding important members of this pathway, such as the hedgehog
receptor genes PTCH and SMOH, plays a crucial role in the pathogenesis
of basal cell carcinomas, the most common human cancers. Germline
mutations in the PTCH gene underlie the early and multifocal
development of basal cell carcinomas in patients suffering from nevoid
basal cell carcinoma syndrome. Somatic mutations in PTCH or SMOH as
well as upregulation of different hedgehog target genes are found in the
vast majority of sporadic basal cell carcinomas. In addition, about 50% of
the cases carry mutations in the TP53 tumor suppressor gene. Recent
progress in the understanding of the complex molecular pathogenesis of
basal cell carcinoma, including data obtained from experimental studies
on genetically modified mouse models, will be discussed.
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Genes Involved in Polygenic Inheritance to Melanoma
N Soufir
Laboratoire de Biochimie Hormonale et Ge´ne´tique. Hopital Bichat,
Paris, France
Germline mutations affecting two highly penetrant melanoma-predis-
posing genes, CDKN2A and CDK4, are associated with familial
cutaneous melanoma, which accounts for 5–10% of all melanoma cases.
In addition, there is increasing evidence for a polygenic inheritance of
the predisposition to melanoma, and variant alleles associated with
melanoma risk have been identified at several gene loci, such as genes
involved in DNA repair (XRCC3), reactive oxygen detoxification
(Glutathione S-transferases M1 and T1) and pigmentation (melanocortin
1 receptor, MC1R). In particular, specific loss-of-function MC1R variants
are believed to be low penetrance melanoma-predisposing mutation-
s{Hayward, 2003} that have also been shown to modulate the penetrance
of CDKN2A mutations in melanoma families. Because of the important
role of melanin in protecting the skin against UV radiation, genes that
control melanocyte development or melanogenesis are attractive
candidate, and these include the endothelin system, that plays a crucial
role in melanocyte development, differentiation, and response to UV
radiation. we recently showed in a case-control study that non-
synonymous variants of the endothelin B receptor (EDNRB), a gene
involved in melanocyte differentiation, were associated with melanoma
risk, suggesting that a defect in EDNRB could favour melanoma
development.
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Viruses as Therapeutic Tools in CTCL
R Dummer1, M Urosevic1, S Hemmi2 and P Oberholzer1
1Department of Dermatology, University Hospital of Zurich, Switzerland
and 2Institute of Molecular Biology, University of Zurich, Switzerland
The skin is the organ that is most frequently affected by malignant tumors.
Resident cell types such as keratinocytes, melanocytes or fibroblasts may
be the origin for these neoplasms. However, there are also tumors of cell
types that are not found in normal human skin such as T lymphocytes.
Primary cutaneous T-cell lymphomas (CTCL) are a nice example how
profound knowledge of the immune biology can be translated into well
tolerated treatment approaches. We have purified the tumor cell
populations in CTCL patients by the use of monoclonal antibodies
directed against T-cell receptor variable region and studied the cytokine
transcription profile and cytokine responses. The tumor cell populations
preferentially secrete T-helper 2 cytokines (IL-5, IL-10), the Interferon
inhibiting cytokine IK and presented an intact signal transduction
pathway for IL-7 and IL-15. However, Interferon signal transduction
pathways were found to be deficient. This Interferon resistance affects
also the susceptibility for viral infections. Interferon sensitive viruses such
as vesicular stomatitis virus selectively replicate in the tumor cell
population in the presence of exogenous Interferon-alpha. Consequently,
we have initiated a clinical trial using replicating measles virus in CTCL
patients. In order to target the T-helper 2 neoplasms, we have also
initiated a clinical trial using an adenoviral vector of the third generation
expressing Interferon-gamma after demonstrating the expression of the
human adeno- and coxsackie virus receptor in CTCL biopsies. Efficient
expression of the adenovirus encoded Interferon-gamma was detected
after injection. Repetitive injections of the vector resulted in substantial
regressions of injected and non-injected skin lesions in cutaneous T-cell
but also in cutaneous B-cell lymphomas associated with an increase of
reactive cytotoxic mononuclear cells. We are convinced that a detailed
analysis of cancers will identify Achilles heels that can be targeted by
specific molecular interventions. Cutaneous neoplasms are perfect
prototype tumors since they can be easily reached for intralesional
injection and repeated biopsies during therapeutic interventions.
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Mechanisms of Melanoma Metastasis Formation
A Mu¨ller1, SN Wagner2, H Soto3, T McClanahan3, M Sathe3, E Murphy3,
W Yuan3, P Hevezi4, T Ruzicka1, A Zlotnik4 and B Homey1
1Departments of Radiation Oncology and Dermatology, Heinrich-Heine-
University, Du¨sseldorf, Germany, 2Department of Dermatology, Division
of Immunology, Allergy and Infectious Diseases, Medical University of
Vienna and CeMM -Center of Molecular Medicine, Austrian Academy of
Sciences, Vienna, Austria, 3Department of Immunology, DNAX Research
Inc., Palo Alto, CA, USA and 4Neurocrine, San Diego, CA, USA
Malignant melanoma is an aggressive malignant tumor and its high
tendency to metastasize represents the major survival-limiting factor for
patients with this disease. Previously, we reported that chemokine
receptors are involved in site-specific metastasis of breast cancer. Here,
we show that melanoma cells preferentially express two chemokine
receptors, CXCR4 and CCR10. In melanoma, CXCR4 expression directly
correlates with the invasive stage of the primary tumor, is induced by
TGF-beta1 and shows enhancement at the invasive tumor front.
Furthermore, growth factors produced within the local tumor micro-
environment such as bFGF, EGF, and TGF-beta1, or the proinflammatory
cytokines TNF-alpha and IL-1beta induce chemokine receptor expression
on melanoma cells. In vivo, neutralization of CXCL12/CXCR4 interac-
tions results in significant suppression of the development of lung
metastases. Clinically, melanoma is characterized by a high frequency of
skin metastases which correlates with the abundant expression of CCR10,
a receptor binding to the skin-specific chemokine CCL27. Notably,
cutaneous and subcutaneous melanoma metastases exhibit significantly
increased levels of CCR10 suggesting the selection of CCR10-high
expressing melanoma cells. In addition to the induction of migration and
invasion, CCL27 also enhances melanoma cell proliferation in vitro and
in vivo. Taken together, our findings strongly suggest that specific
chemokine receptors play critical roles in tumor progression and
metastasis of malignant melanoma.
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